COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented…
12 out of 14 patients went into remission for three months following a single 25mg dose of COMP360 psilocybin therapy, in an independent investigator-initiated, exploratory open-label study of type II bipolar disorder New data from…